Literature DB >> 17659592

Regulation of ACh receptor clustering by the tyrosine phosphatase Shp2.

Xiaotao T Zhao1, Yueping K Qian, Ariel W S Chan, Raghavan Madhavan, H Benjamin Peng.   

Abstract

At the vertebrate neuromuscular junction (NMJ), postsynaptic aggregation of muscle acetylcholine receptors (AChRs) depends on the activation of MuSK, a muscle-specific tyrosine kinase that is stimulated by neural agrin and regulated by muscle-intrinsic tyrosine kinases and phosphatases. We recently reported that Shp2, a tyrosine phosphatase containing src homology two domains, suppressed MuSK-dependent AChR clustering in cultured myotubes, but how this effect of Shp2 is controlled has remained unclear. In this study, biochemical assays showed that agrin-treatment of C2 mouse myotubes enhanced the tyrosine phosphorylation of signal regulatory protein alpha1 (SIRPalpha1), a known activator of Shp2, and promoted SIRPalpha1's interaction with Shp2. Moreover, in situ experiments revealed that treatment of myotubes with the Shp2-selective inhibitor NSC-87877 increased spontaneous and agrin-induced AChR clustering, and that AChR clustering was also enhanced in myotubes ectopically expressing inactive (dominant-negative) Shp2; in contrast, AChR clustering was reduced in myotubes expressing constitutively active Shp2. Significantly, expression of truncated (nonShp2-binding) and full-length (Shp2-binding) forms of SIRPalpha1 in myotubes also increased and decreased AChR clustering, respectively, and coexpression of truncated SIRPalpha1 with active Shp2 and full-length SIRPalpha1 with inactive Shp2 reversed the actions of the exogenous Shp2 proteins on AChR clustering. These results suggest that SIRPalpha1 is a novel downstream target of MuSK that activates Shp2, which, in turn, suppresses AChR clustering. We propose that an inhibitory loop involving both tyrosine kinases and phosphatases sets the level of agrin/MuSK signaling and constrains it spatially to help generate high-density AChR clusters selectively at NMJs. 2007 Wiley Periodicals, Inc

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17659592     DOI: 10.1002/dneu.20556

Source DB:  PubMed          Journal:  Dev Neurobiol        ISSN: 1932-8451            Impact factor:   3.964


  9 in total

Review 1.  Targeting protein tyrosine phosphatases for anticancer drug discovery.

Authors:  Latanya M Scott; Harshani R Lawrence; Saïd M Sebti; Nicholas J Lawrence; Jie Wu
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

Review 2.  Role of extracellular matrix proteins and their receptors in the development of the vertebrate neuromuscular junction.

Authors:  Neha Singhal; Paul T Martin
Journal:  Dev Neurobiol       Date:  2011-11       Impact factor: 3.964

3.  Evolution and comparative genomics of subcellular specializations: EST sequencing of Torpedo electric organ.

Authors:  Javad Nazarian; Deborah L Berry; Salar Sanjari; Mohammed Razvi; Kristy Brown; Yetrib Hathout; Akos Vertes; Sherry Dadgar; Eric P Hoffman
Journal:  Mar Genomics       Date:  2011-02-12       Impact factor: 1.710

4.  Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112.

Authors:  Liwei Chen; Daniele Pernazza; Latanya M Scott; Harshani R Lawrence; Yuan Ren; Yunting Luo; Xin Wu; Shen-Shu Sung; Wayne C Guida; Said M Sebti; Nicholas J Lawrence; Jie Wu
Journal:  Biochem Pharmacol       Date:  2010-05-25       Impact factor: 5.858

5.  Shp2 regulates migratory behavior and response to EGFR-TKIs through ERK1/2 pathway activation in non-small cell lung cancer cells.

Authors:  Yu-Jing Sun; Zhong-Ling Zhuo; Hai-Peng Xian; Ke-Zhong Chen; Fan Yang; Xiao-Tao Zhao
Journal:  Oncotarget       Date:  2017-08-14

6.  Protein Tyrosine Phosphatase Receptor Type R (PTPRR) Reduces AChR Clustering by Dephosphorylating MuSK.

Authors:  Yanxun Chen; Maohao Guan; Fengqiang Yu; Zhongshan Yang; Weiqiang Yi; Xuan Huang; Ruiqin Qiu; Fancai Lai
Journal:  Dis Markers       Date:  2022-09-05       Impact factor: 3.464

7.  The function of cortactin in the clustering of acetylcholine receptors at the vertebrate neuromuscular junction.

Authors:  Raghavan Madhavan; Zhuolin L Gong; Jin Jin Ma; Ariel W S Chan; H Benjamin Peng
Journal:  PLoS One       Date:  2009-12-29       Impact factor: 3.240

8.  The function of Shp2 tyrosine phosphatase in the dispersal of acetylcholine receptor clusters.

Authors:  Yueping K Qian; Ariel W S Chan; Raghavan Madhavan; H Benjamin Peng
Journal:  BMC Neurosci       Date:  2008-07-23       Impact factor: 3.288

9.  SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody.

Authors:  Saif Huda; Michelangelo Cao; Anna De Rosa; Mark Woodhall; Pedro M Rodriguez Cruz; Judith Cossins; Michelangelo Maestri; Roberta Ricciardi; Amelia Evoli; David Beeson; Angela Vincent
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-12-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.